RNA combination therapy for lung cancer offers promise for personalized medicine
Researchers improve therapeutic response in clinically relevant model of lung-tumor growth.
Koch Institute
A new way to model cancer
New gene-editing technique allows scientists to more rapidly study the role of mutations in tumor development.
Advanced thin-film technique could deliver long-lasting medication
Nanoscale, biodegradable drug-delivery method could provide a year or more of steady doses.
Model of viral lifecycle could help in finding a cure for hepatitis B
New technique sustains virus in liver cells, allowing study of immune response and drug treatments.
Advancing medicine, layer by layer
Studies by graduate students Stephen Morton and Nisarg Shah show progress toward better cancer treatment and bone replacement.
Robert Langer receives Kyoto Prize
Institute Professor cited as "a founder of the field of tissue engineering."
Faculty highlight: Paula Hammond
Engineering tiny paths to cancer treatment, bone regrowth, and wound healing, Paula Hammond serves as an exemplary researcher-educator within the MIT community.
Expanding the power of RNA interference
RNA carried by new nanoparticles can silence genes in many organs, could be deployed to treat cancer.
Chemotherapy timing is key to success
Nanoparticles that stagger delivery of two drugs knock out aggressive tumors in mice.
Fast way to measure DNA repair
Test analyzing cells’ ability to fix different kinds of broken DNA could help doctors predict cancer risk.
Making cancer drugs better
Killian Award recipient Stephen Lippard describes his work on platinum-based chemotherapy agents.
How to build a biotech renaissance: MIT in Kendall Square
A look back at how Institute Professor Phillip Sharp, his startup Biogen, and MIT’s biotech community helped revive Kendall Square.